OpenFISH, an open-source, low-cost spatial transcriptomics platform, was evaluated for its ability to integrate with MALDI mass spectrometry imaging (MALDI-MSI) on the same tissue section, enabling co-mapping of cell-type identity (transcripts) and metabolic state (metabolites) at single-cell resolution in the central nervous system.
OpenFISH successfully enabled same-section, cell-type-aware co-mapping of transcripts and metabolites, revealing cell-type-specific metabolic heterogeneity, hippocampal metabolic zonation, and—in 5xFAD Alzheimer's model tissue—phospholipid changes in microglia, metabolic shifts in excitatory neurons hidden in bulk analyses, and elevated lysophosphatidylethanolamine-related features in oligodendrocytes.
Findings from 5xFAD and Reeler mutant experiments are described as 'exploratory,' limiting causal or clinical conclusions; the platform has been demonstrated primarily in CNS tissue, so generalizability to other organs is unproven; single-cell metabolite spatial resolution depends on MALDI-MSI technical constraints.
OpenFISH offers a customizable, low-cost framework for researchers to link cell identity to metabolic state within the same tissue section—currently a research tool rather than a clinical one, but it may accelerate mechanistic understanding of diseases like Alzheimer's where cell-type-specific metabolic changes are relevant.
Explore related topics